# pathway_0117: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0117.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MYDVIVVGAGWCGLAAAKTYLQTCPTARLLVVDGDSSIGGTWSKERLYPHLVAEAHYGLFEFSDLPMRREGILPDGRIPSAAVHAYLTEYATKFGLLPRIRLNTWIEDIRQDPTAIGDDKAPYWTLQVAGSSQPLQARKLIIATGLTSEPRMPSFPGREDFEGHVLHSKMMGRADTGKLLNDPSIRHVVVYGGSKSAFDAVYLLLRAGKTVDWVIREGGGGPSIMTPLNILGQPSFRLNNSRVMSLFSPNPFEVAGERSWWQRVMHQRAGTFAQLLVVWFWRVLAYLLQRPWKYDYSVNGKQLKPILGLDSVLWSPATLGVMTHPTLWEDIHSGERVTIRRQNITALGQNKHVVLSNGDRITADMVVCATGWHARHSLFTPDEQLAVGLPSTSSFDPKSQAHWLNLQKAADEEILEEFPLLQNCPIALPPVRCEDDHHLYRFVAPSSGPLAQERLIAYVGFLRTTGAPIVYEAQSLWATAYLTGALHVPALEEREKEVARTNAWIRRRYICGRKVPFALFDFLPYVDMLYRDLGVNSRRKKNAVSE

[Multiple Choices]
A. Alkaloid biosynthesis
B. Antifungal biosynthesis. .
C. chorismate from D-erythrose 4-phosphate and phosphoenolpyruvate: step 7/7. .
D. tetrahydrofolate biosynthesis
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt entry annotated with the pathway “Antifungal biosynthesis.” The annotation is linked to a cited publication, though the supplied evidence does not independently establish the experimental basis for that assignment.

Citations as saved: [H3](#evidence-h3), [C5](#evidence-c5), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is annotated as a FAD-dependent monooxygenase, but that broad enzyme class does not by itself distinguish antifungal biosynthesis from the other listed pathways.


**Missing item-specific fact**

> The protein-specific association with the antifungal biosynthetic pathway, reported in the cited literature and database annotation.


**Reason**

> The pathway association is not provided in the question. Recognizing the sequence or retrieving its protein-specific annotation would be needed to select B; generic sequence-based enzyme-family clues do not establish that pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched sequence’s pathway annotation supports B; the other choices are not supported by the supplied sequence information alone.


### Important caveats

- The pathway annotation is database evidence associated with a publication, not an independently reviewed experimental result in the supplied evidence.
- The exact author source snapshot is unknown, although the sequence matches both the archived and current UniProt records.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is annotated as a FAD-dependent monooxygenase, but that broad enzyme class does not by itself distinguish antifungal biosynthesis from the other listed pathways.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific association with the antifungal biosynthetic pathway, reported in the cited literature and database annotation.",
    "reason": "The pathway association is not provided in the question. Recognizing the sequence or retrieving its protein-specific annotation would be needed to select B; generic sequence-based enzyme-family clues do not establish that pathway."
  },
  "case_id": "pathway_0117",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "C5",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated with the pathway “Antifungal biosynthesis.” The annotation is linked to a cited publication, though the supplied evidence does not independently establish the experimental basis for that assignment."
  },
  "important_caveats": [
    "The pathway annotation is database evidence associated with a publication, not an independently reviewed experimental result in the supplied evidence.",
    "The exact author source snapshot is unknown, although the sequence matches both the archived and current UniProt records."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched sequence’s pathway annotation supports B; the other choices are not supported by the supplied sequence information alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0117",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated with the pathway “Antifungal biosynthesis.” The annotation is linked to a cited publication, though the supplied evidence does not independently establish the experimental basis for that assignment.",
    "evidence_ids": ["H3", "C5", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is annotated as a FAD-dependent monooxygenase, but that broad enzyme class does not by itself distinguish antifungal biosynthesis from the other listed pathways.",
    "missing_item_specific_fact": "The protein-specific association with the antifungal biosynthetic pathway, reported in the cited literature and database annotation.",
    "reason": "The pathway association is not provided in the question. Recognizing the sequence or retrieving its protein-specific annotation would be needed to select B; generic sequence-based enzyme-family clues do not establish that pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched sequence’s pathway annotation supports B; the other choices are not supported by the supplied sequence information alone."
  },
  "important_caveats": [
    "The pathway annotation is database evidence associated with a publication, not an independently reviewed experimental result in the supplied evidence.",
    "The exact author source snapshot is unknown, although the sequence matches both the archived and current UniProt records."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXV6 (LAN4_PYRDE) explicitly annotates the pathway as 'Antifungal biosynthesis' (evidence C5, H3), supported by PubMed:33857369. The protein is a FAD-dependent monooxygenase in the lanomycin biosynthetic gene cluster of Pyrenophora dematioidea. Lanomycin is a natural product CYP51 inhibitor (antifungal agent), making the pathway annotation 'Antifungal biosynthesis' (i.e., biosynthesis of an antifungal compound) scientifically accurate. The sequence matches the reviewed entry exactly.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence shows a FAD-dependent monooxygenase (Rossmann-fold-like GxGxxG motifs near N-terminus, GGGK nucleotide-binding motifs) from a fungal source. Options C (shikimate pathway step 7/7, EPSP synthase) and D (tetrahydrofolate biosynthesis) can be excluded by general knowledge: these involve specific bacterial/plant enzymes unrelated to fungal FAD monooxygenases. However, distinguishing 'Antifungal biosynthesis' (B) from 'Alkaloid biosynthesis' (A) requires knowing that this particular FAD monooxygenase participates in lanomycin biosynthesis and that lanomycin is classified as an antifungal CYP51 inhibitor rather than an alkaloid. No sequence feature or general biological principle distinguishes a fungal secondary-metabolite FAD monooxygenase as belonging to 'antifungal biosynthesis' versus 'alkaloid biosynthesis' without the item-specific gene-cluster annotation.


**Missing item-specific fact**

> The identity of this protein as 'Lanomycin biosynthesis cluster protein 4' and the classification of lanomycin as an antifungal compound (CYP51 inhibitor) rather than an alkaloid. This is a protein-specific database annotation (PubMed:33857369) not derivable from the amino acid sequence alone.


**Reason**

> While options C and D are eliminable by general pathway knowledge, the critical discrimination between A and B requires knowing the specific biosynthetic gene cluster membership and the pharmacological classification of the product (lanomycin = antifungal, not alkaloid). This is an item-specific annotation fact.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options C and D are clearly incorrect for a fungal FAD monooxygenase. Option A (Alkaloid biosynthesis) is a plausible-sounding distractor for a fungal secondary-metabolite enzyme but is factually wrong since lanomycin is a polyene macrolide-type antifungal, not an alkaloid. Only B matches the UniProt pathway annotation. No other option is genuinely defensible given the actual protein identity.


### Important caveats

- The UniProt pathway annotation 'Antifungal biosynthesis' refers to biosynthesis of an antifungal compound (lanomycin), not to a host-defense antifungal pathway. The phrasing could confuse a reader into thinking it refers to the organism's own antifungal defense.
- The entry was first publicly released on 2025-02-05 (entry version 2 archived by 2025-04-09). If the benchmark was constructed before this date, the annotation may not have been available in the author's source snapshot.
- The pathway label 'Antifungal biosynthesis' is a UniProt-curated term specific to this gene cluster; it is not a standard KEGG/MetaCyc pathway name, which may affect generalizability of the answer format.
- All reviewer evidence is post-hoc and was absent from the evaluated model's input.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence shows a FAD-dependent monooxygenase (Rossmann-fold-like GxGxxG motifs near N-terminus, GGGK nucleotide-binding motifs) from a fungal source. Options C (shikimate pathway step 7/7, EPSP synthase) and D (tetrahydrofolate biosynthesis) can be excluded by general knowledge: these involve specific bacterial/plant enzymes unrelated to fungal FAD monooxygenases. However, distinguishing 'Antifungal biosynthesis' (B) from 'Alkaloid biosynthesis' (A) requires knowing that this particular FAD monooxygenase participates in lanomycin biosynthesis and that lanomycin is classified as an antifungal CYP51 inhibitor rather than an alkaloid. No sequence feature or general biological principle distinguishes a fungal secondary-metabolite FAD monooxygenase as belonging to 'antifungal biosynthesis' versus 'alkaloid biosynthesis' without the item-specific gene-cluster annotation.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identity of this protein as 'Lanomycin biosynthesis cluster protein 4' and the classification of lanomycin as an antifungal compound (CYP51 inhibitor) rather than an alkaloid. This is a protein-specific database annotation (PubMed:33857369) not derivable from the amino acid sequence alone.",
    "reason": "While options C and D are eliminable by general pathway knowledge, the critical discrimination between A and B requires knowing the specific biosynthetic gene cluster membership and the pharmacological classification of the product (lanomycin = antifungal, not alkaloid). This is an item-specific annotation fact."
  },
  "case_id": "pathway_0117",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXV6 (LAN4_PYRDE) explicitly annotates the pathway as 'Antifungal biosynthesis' (evidence C5, H3), supported by PubMed:33857369. The protein is a FAD-dependent monooxygenase in the lanomycin biosynthetic gene cluster of Pyrenophora dematioidea. Lanomycin is a natural product CYP51 inhibitor (antifungal agent), making the pathway annotation 'Antifungal biosynthesis' (i.e., biosynthesis of an antifungal compound) scientifically accurate. The sequence matches the reviewed entry exactly."
  },
  "important_caveats": [
    "The UniProt pathway annotation 'Antifungal biosynthesis' refers to biosynthesis of an antifungal compound (lanomycin), not to a host-defense antifungal pathway. The phrasing could confuse a reader into thinking it refers to the organism's own antifungal defense.",
    "The entry was first publicly released on 2025-02-05 (entry version 2 archived by 2025-04-09). If the benchmark was constructed before this date, the annotation may not have been available in the author's source snapshot.",
    "The pathway label 'Antifungal biosynthesis' is a UniProt-curated term specific to this gene cluster; it is not a standard KEGG/MetaCyc pathway name, which may affect generalizability of the answer format.",
    "All reviewer evidence is post-hoc and was absent from the evaluated model's input."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are clearly incorrect for a fungal FAD monooxygenase. Option A (Alkaloid biosynthesis) is a plausible-sounding distractor for a fungal secondary-metabolite enzyme but is factually wrong since lanomycin is a polyene macrolide-type antifungal, not an alkaloid. Only B matches the UniProt pathway annotation. No other option is genuinely defensible given the actual protein identity."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0117",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P0DXV6 (LAN4_PYRDE) explicitly annotates the pathway as 'Antifungal biosynthesis' (evidence C5, H3), supported by PubMed:33857369. The protein is a FAD-dependent monooxygenase in the lanomycin biosynthetic gene cluster of Pyrenophora dematioidea. Lanomycin is a natural product CYP51 inhibitor (antifungal agent), making the pathway annotation 'Antifungal biosynthesis' (i.e., biosynthesis of an antifungal compound) scientifically accurate. The sequence matches the reviewed entry exactly.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence shows a FAD-dependent monooxygenase (Rossmann-fold-like GxGxxG motifs near N-terminus, GGGK nucleotide-binding motifs) from a fungal source. Options C (shikimate pathway step 7/7, EPSP synthase) and D (tetrahydrofolate biosynthesis) can be excluded by general knowledge: these involve specific bacterial/plant enzymes unrelated to fungal FAD monooxygenases. However, distinguishing 'Antifungal biosynthesis' (B) from 'Alkaloid biosynthesis' (A) requires knowing that this particular FAD monooxygenase participates in lanomycin biosynthesis and that lanomycin is classified as an antifungal CYP51 inhibitor rather than an alkaloid. No sequence feature or general biological principle distinguishes a fungal secondary-metabolite FAD monooxygenase as belonging to 'antifungal biosynthesis' versus 'alkaloid biosynthesis' without the item-specific gene-cluster annotation.",
    "missing_item_specific_fact": "The identity of this protein as 'Lanomycin biosynthesis cluster protein 4' and the classification of lanomycin as an antifungal compound (CYP51 inhibitor) rather than an alkaloid. This is a protein-specific database annotation (PubMed:33857369) not derivable from the amino acid sequence alone.",
    "reason": "While options C and D are eliminable by general pathway knowledge, the critical discrimination between A and B requires knowing the specific biosynthetic gene cluster membership and the pharmacological classification of the product (lanomycin = antifungal, not alkaloid). This is an item-specific annotation fact."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are clearly incorrect for a fungal FAD monooxygenase. Option A (Alkaloid biosynthesis) is a plausible-sounding distractor for a fungal secondary-metabolite enzyme but is factually wrong since lanomycin is a polyene macrolide-type antifungal, not an alkaloid. Only B matches the UniProt pathway annotation. No other option is genuinely defensible given the actual protein identity."
  },
  "important_caveats": [
    "The UniProt pathway annotation 'Antifungal biosynthesis' refers to biosynthesis of an antifungal compound (lanomycin), not to a host-defense antifungal pathway. The phrasing could confuse a reader into thinking it refers to the organism's own antifungal defense.",
    "The entry was first publicly released on 2025-02-05 (entry version 2 archived by 2025-04-09). If the benchmark was constructed before this date, the annotation may not have been available in the author's source snapshot.",
    "The pathway label 'Antifungal biosynthesis' is a UniProt-curated term specific to this gene cluster; it is not a standard KEGG/MetaCyc pathway name, which may affect generalizability of the answer format.",
    "All reviewer evidence is post-hoc and was absent from the evaluated model's input."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt records annotate this protein's pathway as antifungal biosynthesis and link that annotation to a publication. This supports the author's key as a database attribution, though the cited annotation alone is not independent verification of the underlying experimental evidence.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence's N-terminal glycine-rich FAD-binding-like motif is consistent with a flavin-dependent enzyme, plausibly a monooxygenase. That enzyme class can participate in diverse biosynthetic pathways, so it does not distinguish antifungal from alkaloid biosynthesis. It makes the specific chorismate-synthesis choice less plausible, but does not resolve the key distinction between A and B.


**Missing item-specific fact**

> The protein's pathway or biosynthetic-cluster assignment, such as evidence linking it to a particular antifungal product rather than an alkaloid pathway.


**Reason**

> The sequence provides a broad enzyme-class clue, not a pathway-specific signature that meaningfully separates the two secondary-metabolite options. Choosing B requires protein- or cluster-specific pathway information absent from the original inputs.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> From the supplied sequence alone, a flavin-dependent enzyme could plausibly act in either alkaloid or antifungal biosynthesis; the sequence does not identify the product pathway.


### Important caveats

- The cited pathway annotation supports the answer as a database attribution; the primary publication was not independently assessed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence's N-terminal glycine-rich FAD-binding-like motif is consistent with a flavin-dependent enzyme, plausibly a monooxygenase. That enzyme class can participate in diverse biosynthetic pathways, so it does not distinguish antifungal from alkaloid biosynthesis. It makes the specific chorismate-synthesis choice less plausible, but does not resolve the key distinction between A and B.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's pathway or biosynthetic-cluster assignment, such as evidence linking it to a particular antifungal product rather than an alkaloid pathway.",
    "reason": "The sequence provides a broad enzyme-class clue, not a pathway-specific signature that meaningfully separates the two secondary-metabolite options. Choosing B requires protein- or cluster-specific pathway information absent from the original inputs."
  },
  "case_id": "pathway_0117",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt records annotate this protein's pathway as antifungal biosynthesis and link that annotation to a publication. This supports the author's key as a database attribution, though the cited annotation alone is not independent verification of the underlying experimental evidence."
  },
  "important_caveats": [
    "The cited pathway annotation supports the answer as a database attribution; the primary publication was not independently assessed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "From the supplied sequence alone, a flavin-dependent enzyme could plausibly act in either alkaloid or antifungal biosynthesis; the sequence does not identify the product pathway."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0117",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt records annotate this protein's pathway as antifungal biosynthesis and link that annotation to a publication. This supports the author's key as a database attribution, though the cited annotation alone is not independent verification of the underlying experimental evidence.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence's N-terminal glycine-rich FAD-binding-like motif is consistent with a flavin-dependent enzyme, plausibly a monooxygenase. That enzyme class can participate in diverse biosynthetic pathways, so it does not distinguish antifungal from alkaloid biosynthesis. It makes the specific chorismate-synthesis choice less plausible, but does not resolve the key distinction between A and B.",
    "missing_item_specific_fact": "The protein's pathway or biosynthetic-cluster assignment, such as evidence linking it to a particular antifungal product rather than an alkaloid pathway.",
    "reason": "The sequence provides a broad enzyme-class clue, not a pathway-specific signature that meaningfully separates the two secondary-metabolite options. Choosing B requires protein- or cluster-specific pathway information absent from the original inputs."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "From the supplied sequence alone, a flavin-dependent enzyme could plausibly act in either alkaloid or antifungal biosynthesis; the sequence does not identify the product pathway."
  },
  "important_caveats": [
    "The cited pathway annotation supports the answer as a database attribution; the primary publication was not independently assessed here."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXV6 (LAN4_PYRDE) explicitly annotates PATHWAY: Antifungal biosynthesis (ECO:0000305|PubMed:33857369). The protein is 'Lanomycin biosynthesis cluster protein 4,' a FAD-dependent monooxygenase in the lanomycin BGC. Lanomycin is a natural-product CYP51 inhibitor with antifungal activity, as characterized in Liu et al. 2021 JACS. The pathway assignment is a curator inference from the BGC context and functional characterization in the cited paper.

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains multiple GxGxxG motifs (GAGWCGLAA, GGSKSAFDA, GGGGPSIM, GGERSWW) diagnostic of FAD-binding flavoproteins/monooxygenases. This allows elimination of C (chorismate synthase, a distinct FMN-dependent enzyme with different architecture) and D (tetrahydrofolate pathway enzymes such as DHFR, dihydropteroate synthase, GTP cyclohydrolase I, which have entirely different folds and motifs). However, FAD-dependent monooxygenases are ubiquitous tools in ALL secondary metabolite biosynthetic gene clusters, including alkaloid, antifungal, polyketide, and terpenoid pathways. The sequence provides no feature that specifically signals 'antifungal' over 'alkaloid' biosynthesis. Distinguishing B from A requires knowing this protein is ORF4 of the lanomycin BGC in Pyrenophora dematioidea, a fact about this exact protein's genomic context.


**Missing item-specific fact**

> The specific assignment of this FAD-dependent monooxygenase to the lanomycin (antifungal CYP51 inhibitor) biosynthetic gene cluster in Pyrenophora dematioidea, as established by genome mining in Liu et al. 2021. This BGC membership is not encoded in the amino acid sequence itself and cannot be inferred from general FAD-monooxygenase family knowledge.


**Reason**

> While the FAD-binding architecture permits elimination of primary metabolic pathway options C and D, the remaining choice between A (alkaloid biosynthesis) and B (antifungal biosynthesis) both describe secondary metabolite pathways that commonly employ FAD-dependent monooxygenases. No sequence motif, domain arrangement, or family-level analogy distinguishes an antifungal-pathway monooxygenase from an alkaloid-pathway monooxygenase. The correct answer requires knowledge of this protein's membership in the lanomycin BGC, which is a fact specific to this exact protein.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Both alkaloid biosynthesis and antifungal biosynthesis are secondary metabolite pathways that routinely incorporate FAD-dependent monooxygenases with the same GxGxxG binding motifs observed here. Without BGC context or organism identity, a knowledgeable model cannot preferentially select B over A based on sequence features alone.


### Important caveats

- The UniProt pathway annotation uses evidence code ECO:0000305 (curator inference from literature), not direct experimental proof of this single enzyme's catalytic step in antifungal biosynthesis.
- 'Antifungal biosynthesis' in UniProt refers to biosynthesis of antifungal secondary metabolites (lanomycin), not biosynthesis of an antifungal defense response.
- The entry was first released in February 2025; the benchmark's construction date relative to this release is unknown.
- The sequence's fungal origin is not explicitly provided in the question input, though amino acid composition might weakly suggest eukaryotic origin.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains multiple GxGxxG motifs (GAGWCGLAA, GGSKSAFDA, GGGGPSIM, GGERSWW) diagnostic of FAD-binding flavoproteins/monooxygenases. This allows elimination of C (chorismate synthase, a distinct FMN-dependent enzyme with different architecture) and D (tetrahydrofolate pathway enzymes such as DHFR, dihydropteroate synthase, GTP cyclohydrolase I, which have entirely different folds and motifs). However, FAD-dependent monooxygenases are ubiquitous tools in ALL secondary metabolite biosynthetic gene clusters, including alkaloid, antifungal, polyketide, and terpenoid pathways. The sequence provides no feature that specifically signals 'antifungal' over 'alkaloid' biosynthesis. Distinguishing B from A requires knowing this protein is ORF4 of the lanomycin BGC in Pyrenophora dematioidea, a fact about this exact protein's genomic context.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific assignment of this FAD-dependent monooxygenase to the lanomycin (antifungal CYP51 inhibitor) biosynthetic gene cluster in Pyrenophora dematioidea, as established by genome mining in Liu et al. 2021. This BGC membership is not encoded in the amino acid sequence itself and cannot be inferred from general FAD-monooxygenase family knowledge.",
    "reason": "While the FAD-binding architecture permits elimination of primary metabolic pathway options C and D, the remaining choice between A (alkaloid biosynthesis) and B (antifungal biosynthesis) both describe secondary metabolite pathways that commonly employ FAD-dependent monooxygenases. No sequence motif, domain arrangement, or family-level analogy distinguishes an antifungal-pathway monooxygenase from an alkaloid-pathway monooxygenase. The correct answer requires knowledge of this protein's membership in the lanomycin BGC, which is a fact specific to this exact protein."
  },
  "case_id": "pathway_0117",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXV6 (LAN4_PYRDE) explicitly annotates PATHWAY: Antifungal biosynthesis (ECO:0000305|PubMed:33857369). The protein is 'Lanomycin biosynthesis cluster protein 4,' a FAD-dependent monooxygenase in the lanomycin BGC. Lanomycin is a natural-product CYP51 inhibitor with antifungal activity, as characterized in Liu et al. 2021 JACS. The pathway assignment is a curator inference from the BGC context and functional characterization in the cited paper."
  },
  "important_caveats": [
    "The UniProt pathway annotation uses evidence code ECO:0000305 (curator inference from literature), not direct experimental proof of this single enzyme's catalytic step in antifungal biosynthesis.",
    "'Antifungal biosynthesis' in UniProt refers to biosynthesis of antifungal secondary metabolites (lanomycin), not biosynthesis of an antifungal defense response.",
    "The entry was first released in February 2025; the benchmark's construction date relative to this release is unknown.",
    "The sequence's fungal origin is not explicitly provided in the question input, though amino acid composition might weakly suggest eukaryotic origin."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Both alkaloid biosynthesis and antifungal biosynthesis are secondary metabolite pathways that routinely incorporate FAD-dependent monooxygenases with the same GxGxxG binding motifs observed here. Without BGC context or organism identity, a knowledgeable model cannot preferentially select B over A based on sequence features alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{"case_id":"pathway_0117","expected_answer_check":{"judgment":"supported","reason":"UniProt entry P0DXV6 (LAN4_PYRDE) explicitly annotates PATHWAY: Antifungal biosynthesis (ECO:0000305|PubMed:33857369). The protein is 'Lanomycin biosynthesis cluster protein 4,' a FAD-dependent monooxygenase in the lanomycin BGC. Lanomycin is a natural-product CYP51 inhibitor with antifungal activity, as characterized in Liu et al. 2021 JACS. The pathway assignment is a curator inference from the BGC context and functional characterization in the cited paper.","evidence_ids":["C5","C4","C6","H3"]},"answerability_check":{"judgment":"lookup_or_memorization_dependent","discriminating_biological_argument":"The sequence contains multiple GxGxxG motifs (GAGWCGLAA, GGSKSAFDA, GGGGPSIM, GGERSWW) diagnostic of FAD-binding flavoproteins/monooxygenases. This allows elimination of C (chorismate synthase, a distinct FMN-dependent enzyme with different architecture) and D (tetrahydrofolate pathway enzymes such as DHFR, dihydropteroate synthase, GTP cyclohydrolase I, which have entirely different folds and motifs). However, FAD-dependent monooxygenases are ubiquitous tools in ALL secondary metabolite biosynthetic gene clusters, including alkaloid, antifungal, polyketide, and terpenoid pathways. The sequence provides no feature that specifically signals 'antifungal' over 'alkaloid' biosynthesis. Distinguishing B from A requires knowing this protein is ORF4 of the lanomycin BGC in Pyrenophora dematioidea, a fact about this exact protein's genomic context.","missing_item_specific_fact":"The specific assignment of this FAD-dependent monooxygenase to the lanomycin (antifungal CYP51 inhibitor) biosynthetic gene cluster in Pyrenophora dematioidea, as established by genome mining in Liu et al. 2021. This BGC membership is not encoded in the amino acid sequence itself and cannot be inferred from general FAD-monooxygenase family knowledge.","reason":"While the FAD-binding architecture permits elimination of primary metabolic pathway options C and D, the remaining choice between A (alkaloid biosynthesis) and B (antifungal biosynthesis) both describe secondary metabolite pathways that commonly employ FAD-dependent monooxygenases. No sequence motif, domain arrangement, or family-level analogy distinguishes an antifungal-pathway monooxygenase from an alkaloid-pathway monooxygenase. The correct answer requires knowledge of this protein's membership in the lanomycin BGC, which is a fact specific to this exact protein."},"question_ambiguity":{"multiple_defensible_options":["A","B"],"reason":"Both alkaloid biosynthesis and antifungal biosynthesis are secondary metabolite pathways that routinely incorporate FAD-dependent monooxygenases with the same GxGxxG binding motifs observed here. Without BGC context or organism identity, a knowledgeable model cannot preferentially select B over A based on sequence features alone."},"important_caveats":["The UniProt pathway annotation uses evidence code ECO:0000305 (curator inference from literature), not direct experimental proof of this single enzyme's catalytic step in antifungal biosynthesis.","'Antifungal biosynthesis' in UniProt refers to biosynthesis of antifungal secondary metabolites (lanomycin), not biosynthesis of an antifungal defense response.","The entry was first released in February 2025; the benchmark's construction date relative to this release is unknown.","The sequence's fungal origin is not explicitly provided in the question input, though amino acid composition might weakly suggest eukaryotic origin."]}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXV6",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "7df1c302f7926e2d8ce67872cea5f1885a96c661666cec76e87fe2b497b1dc21",
  "benchmark_sequence_length": 546,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 4,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "604f2ff191211f3fc9173924778cd268cd13201aacb65262a9cd48362829e340",
  "current_source_sequence_sha256": "7df1c302f7926e2d8ce67872cea5f1885a96c661666cec76e87fe2b497b1dc21",
  "current_source_sequence_length": 546,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 2,
  "selected_historical_version": {
    "accession": "P0DXV6",
    "database": "Swiss-Prot",
    "entryVersion": 2,
    "firstRelease": "2025_02/2025_02",
    "firstReleaseDate": "23-Apr-2025",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "LAN4_PYRDE",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "1aa3327dc9591ccf3b323653d57490eeb83ea02899e48e37df4e6dc51b099591",
  "selected_historical_source_sequence_sha256": "7df1c302f7926e2d8ce67872cea5f1885a96c661666cec76e87fe2b497b1dc21",
  "selected_historical_source_sequence_length": 546,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 2,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV6.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV6.json",
  "source_sha256": "604f2ff191211f3fc9173924778cd268cd13201aacb65262a9cd48362829e340",
  "retrieved_utc": "2026-11-02T04:29:48.282490+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXV6\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV6.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV6.json",
  "source_sha256": "604f2ff191211f3fc9173924778cd268cd13201aacb65262a9cd48362829e340",
  "retrieved_utc": "2026-11-02T04:29:48.282490+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":4,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV6.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV6.json",
  "source_sha256": "604f2ff191211f3fc9173924778cd268cd13201aacb65262a9cd48362829e340",
  "retrieved_utc": "2026-11-02T04:29:48.282490+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Helminthosporium dematioideum\",\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Dothideomycetes\",\"Pleosporomycetidae\",\"Pleosporales\",\"Pleosporineae\",\"Pleosporaceae\",\"Pyrenophora\"],\"scientificName\":\"Pyrenophora dematioidea\",\"taxonId\":139229}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV6.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV6.json",
  "source_sha256": "604f2ff191211f3fc9173924778cd268cd13201aacb65262a9cd48362829e340",
  "retrieved_utc": "2026-11-02T04:29:48.282490+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Lanomycin biosynthesis cluster protein 4\"}}],\"flag\":\"Precursor\",\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"1.-.-.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"FAD-dependent monooxygenase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV6.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV6.json",
  "source_sha256": "604f2ff191211f3fc9173924778cd268cd13201aacb65262a9cd48362829e340",
  "retrieved_utc": "2026-11-02T04:29:48.282490+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV6.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV6.json",
  "source_sha256": "604f2ff191211f3fc9173924778cd268cd13201aacb65262a9cd48362829e340",
  "retrieved_utc": "2026-11-02T04:29:48.282490+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"TTI-1096\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV6?format=txt&versions=2)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV6?format=txt&versions=2",
  "source_sha256": "1aa3327dc9591ccf3b323653d57490eeb83ea02899e48e37df4e6dc51b099591",
  "retrieved_utc": "2026-11-02T04:29:50.838620+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   LAN4_PYRDE              Reviewed;         546 AA.\nAC   P0DXV6;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   09-APR-2025, entry version 2.\nDE   RecName: Full=FAD-dependent monooxygenase {ECO:0000303|PubMed:33857369};\nDE            EC=1.-.-.- {ECO:0000305|PubMed:33857369};\nDE   AltName: Full=Lanomycin biosynthesis cluster protein 4 {ECO:0000303|PubMed:33857369};\nDE   Flags: Precursor;\nGN   Name=ORF4 {ECO:0000303|PubMed:33857369};\nOS   Pyrenophora dematioidea (Helminthosporium dematioideum).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;\nOC   Pleosporomycetidae; Pleosporales; Pleosporineae; Pleosporaceae;\nOC   Pyrenophora.\nOX   NCBI_TaxID=139229;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV6?format=txt&versions=2)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV6?format=txt&versions=2",
  "source_sha256": "1aa3327dc9591ccf3b323653d57490eeb83ea02899e48e37df4e6dc51b099591",
  "retrieved_utc": "2026-11-02T04:29:50.838620+00:00",
  "source_locator": "lines 16-24",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRC   STRAIN=TTI-1096;\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV6?format=txt&versions=2)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV6?format=txt&versions=2",
  "source_sha256": "1aa3327dc9591ccf3b323653d57490eeb83ea02899e48e37df4e6dc51b099591",
  "retrieved_utc": "2026-11-02T04:29:50.838620+00:00",
  "source_locator": "lines 37-37",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000305|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 117. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
